source
- J&J to acquire Firefly Bio for $1 billion, adding degrader-antibody conjugate technologyJ&J announced it will acquire biotech startup Firefly Bio in an all‑cash transaction valued at $1 billion. The deal gives J&J access to Firefly’s degrader‑antibody conjugate platform, which blends…
- Congo Ebola frontline health workers face low pay and exhaustion amid outbreakDr. Richard Lokudu, medical director of Mongbwalu General Referral Hospital, says he and his colleagues are receiving almost no compensation while treating patients in the current Ebola outbreak.…